Nocopi Technologies triples revenue base with $2.65M acquisition of Polymeric
What's the deal? Nocopi Technologies, a developer of specialty reactive inks traded on the OTCQB under the ticker NNUP, has acquired substantially all the assets of Kansas City-based Polymeric US for $2.65M. The deal was paid through $1.75M in cash, $750K in equity (500,000 shares at $1.50 per share), and US$97.1K holdback. Nocopi expects the acquisition to be accretive to earnings within the year.
Polymeric, founded in 1993 by chemists and colorists, generated over $5M in revenue for the trailing 12 months ended March 31, 2026, with what the company describes as "historically attractive" pre-tax operating income margins. Combined with Nocopi's existing operations, the deal more than triples the company's revenue base.
Alongside the acquisition, Nocopi appointed Gregory S. Babe — former president and chief executive officer of Bayer Corporation — as executive director of operations. Babe also made a personal investment in the company. An affiliate of Horizon Kinetics, an asset management firm, made an additional investment as well.
Why now? Nocopi is a small public company looking to scale its specialty inks business, and Polymeric offers complementary formulation technology, a diversified customer base, and production capacity in the Midwest. Polymeric's top five customers represent less than 25% of total revenue, and its top ten customers average more than five years of relationship tenure — signalling sticky demand.
The acquisition gives Nocopi a second facility: Polymeric's 25,000-square-foot operation staffed by nearly 20 professionals. Polymeric will continue operating under its own brand, led by Dr. Deverakonda Sarma, who has over three decades of formulation experience.
What could go wrong? Integrating two small specialty manufacturers is never straightforward. Nocopi must harmonise research and development, production workflows, and customer management across geographies — all while preserving the customer relationships that make Polymeric valuable.
There's also the question of scale. Even after tripling revenue, the combined entity remains a micro-cap company. Competing against larger specialty chemicals players for talent, customers, and capital will remain a challenge.
The signal: This deal reflects a broader pattern of small, publicly traded industrial companies using acquisitions to build scale quickly rather than growing organically. The involvement of Horizon Kinetics — a well-known value-oriented asset manager — and the appointment of a seasoned executive like Babe suggest that backers see a platform-building opportunity in niche specialty chemicals.
For the specialty inks and coatings market, consolidation among smaller players could accelerate as companies seek geographic diversification and broader formulation capabilities to serve increasingly complex customer needs.
Read more: globenewswire.com
